Paindr

🇺🇲 Happy Memorial Day from the team! 🇺🇲

A great time to repost this around the dangers of combining different respiratory suppressants. In particular, the still lurks out there and represents serious risk of !

Never a bad time to remind everyone to beware of combining , , and , as serious adverse outcomes may ensue. Might as well throw in to these risky interactions, as well.

Beware of the “Holy Trinity” - Pain Dr. Happy Memorial Day! A timely reminder to beware of combining opioids, benzodiazepines, and carisoprodol --> can lead to death!!

🎉 NEW BLOG FRIDAY 🎉

In a recent news release, use appeared to "increase" risk of opioid use disorder when combined with prescriptions.

Sounds performative right 🙄 ?

Well, yes, it likely is. Let's dive into the data behind these claims, and what the "study" actually found regarding gabapentin and risk of !

Gabapentin and Opioid Use Disorder: Correlation, Causation, or Callowness? - Pain Dr. In recent news, it appears that gabapentin "increases" risk of opioid use disorder. Is this true? Does gabapentin increase risk?

Only 1 week left to comment on the petition to recognize Pain Management Pharmacy as a pharmacy specialty certification!

The BPS - Board of Pharmacy Specialties is currently considering to recognize the specialty of to be included as a board certification. We could use the help from all types of and alike to vote and comment on this important designation.

Public comment is open until June 2, 2023.

Please comment in detail or just let BPS know you are in support of the specialty!



CC: Society of Pain and Palliative Care Pharmacists Jacqueline Cleary Erica Wegrzyn

Pain Management Pharmacy Petition Public Comment Form 2023 Take this survey powered by surveymonkey.com. Create your own surveys for free.

🚨 Huge news from the FDA! 🚨

A new subcutaneous formulation of (Brixadi) was approved today for opioid use disorder.

Biggest difference compared to current SC bupe?

More flexible dosing ➡ can be dosed once weekly or monthly!

Obviously, great for expanding options for patients. Will certainly be interesting to see costs and insurance coverage coming out the gate 💰 .

FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder The U.S. Food and Drug Administration approved Brixadi to treat moderate to severe opioid use disorder (OUD).

**New PainDr Blog Friday**

May is Mental Health Month, so let’s talk about pain in the brain!

Is pain really just in your head? Should your physical symptoms be dismissed because of some misinterpretation of the biopsychosocial model?

In our latest blog, we address this growing (and concerning) narrative that pain is just in your head and can be treated as such. We debate what the current understanding of the biopsychosocial model is. Finally, we do discuss the realistic goals of behavioral health directed at chronic and acute pain!

Pain - It's All in Your Head! - Pain Dr. Have you been told by doctors that pain is in your head? Well, the complex answer is that pain is in your head. Just not the way they think!